Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2000Cancer

Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?

View Full Paper
Ask AI
Bookmark
Share

Authors

JMJ. Wallis MarshMax Planck Institute for BiologyIDIgor DvorchikUniversity of North Carolina at Chapel HillCBClark A. BonhamUniversity of Virginia

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Marsh et al. (2000) studied this question.

synapsesocial.com/papers/6a81a48ff2736d406858b7c8https://doi.org/10.1002/(sici)1097-0142(20000201)88:3<538::aid-cncr7>3.0.co;2-h
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Rising Incidence of Hepatocellular Carcinoma in the United States1999 · 2,867 citations
  2. 2Analysis of factors affecting outcome after hepatectomy of patients with liver cirrhosis and small hepatocellular carcinoma2002 · 31 citations
  3. 3Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation1991 · 255 citations
  4. 4Natural killer cell activity in patients with hepatocellular carcinoma1998 · 136 citations
  5. 5Liver transplantation for small hepatocellular carcinoma: The tumor-node-metastasis classification does not have prognostic power1998 · 383 citations